Engineering a biomimetic matrix to promote development of human ovarian follicles in vitro
工程仿生基质促进人类卵泡体外发育
基本信息
- 批准号:10311304
- 负责人:
- 金额:$ 4.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-19 至 2024-08-18
- 项目状态:已结题
- 来源:
- 关键词:AgeAngiopoietinsApoptoticAtlasesAutologous TransplantationAutomobile DrivingBasement membraneBioinformaticsBiologicalBiomimeticsCaliberCancer SurvivorCell ProliferationCellsCharacteristicsChemistryClinicClinicalComplexComputational BiologyCortex of ovaryCoupledCryopreservationData SetDepositionDevelopmentDissociationEmbryoEndocrineEngineeringEnvironmentExtracellular MatrixExtracellular Matrix ProteinsFertilityFertilizationFlow CytometryFluorescenceFutureGene Expression ProfileGene Expression ProfilingGerm CellsGoalsGrowthGrowth FactorHormonalHormone ResponsiveHormonesHumanHydrogelsIn VitroIndividualInfertilityKnowledgeLifeLigand BindingMalignant NeoplasmsMechanicsMethodsMolecular BiologyMusNatureOocytesOvarianOvarian FollicleOvarian TissueOvarian tissue cryopreservationOvaryPGF geneParacrine CommunicationPathway interactionsPatientsPeptide HydrolasesPeptidesPlatelet-Derived Growth FactorPopulationPregnancyPrimordial FollicleProceduresProtocols documentationReproducibilityResearchRiskRoleSavingsSignal TransductionSomatic CellSorting - Cell MovementStainsStandardizationStimulusStromal CellsStructureSupplementationSupport SystemSuspensionsSystemTissue EngineeringTranslatingTranslationsVascular Endothelial Growth FactorsWomanWorkagedangiogenesisanticancer treatmentautocrinebasecancer cellcancer recurrencecancer riskcancer therapycomparativecytokinecytotoxicdesigneggethylene glycolfertility improvementfertility preservationfolliculogenesisgirlshuman tissueimprovedin vivoinnovationnext generation sequencingnoveloocyte cryopreservationoocyte retrievalparacrineprepubertyprimary ovarian insufficiencyprospectivereproductivescaffoldself assemblysingle cell sequencingsingle-cell RNA sequencingstandard of caresuccessthree dimensional structuretissue culturetranscription factortranscriptometranscriptomics
项目摘要
The long-term goal of the proposed research is to establish a broad fertility preservation option for women undergoing gonadotoxic anticancer treatments and facing infertility. The overall objective of this proposal in working towards the presented goal and mitigating the risks associated with autotransplantation is to create a biomimetic environment that promotes human follicle development from the primordial stage in vitro. The low success rates of small follicle culture are largely attributed to the complex and poorly understood paracrine, autocrine and endocrine signaling between follicular cells, neighboring follicles, and stromal cells. The central hypothesis is that transcriptional profiling of human follicles will reveal mechanisms driving development and recreating the ovarian microenvironment through design of a biomimetic hydrogel which retains cell-secreted extracellular matrix (ECM) will support human follicle development in vitro. The rationale for the proposed work is that by deciphering the mechanisms driving follicle activation and early development, and recapitulating the natural ovarian microenvironment in an ECM-sequestering hydrogel, future culture systems can be translated to the clinic for maturation of cryopreserved ovarian follicles and subsequent fertilization and pregnancy. In the first aim, single cell RNA sequencing will be used to profile human ovarian follicles and supportive stromal cells. In the second aim, ECM-sequestering peptides will be incorporated in a biomimetic poly (ethylene glycol) (PEG) hydrogel system using Michael-type addition chemistry to promote deposition of ECM components and mimic the native ovarian tissue. The follicle’s basement membrane is composed of ECM proteins and it functions as structural support for follicular cells, a selective barrier for molecules entering the follicle, and a scaffold for retaining soluble growth factors and cytokines. It is continuously remodeled during follicle development, but cell- secreted ECM molecules are unable to adhere to unmodified PEG for self-assembly. By integrating ECM- sequestering peptides in the PEG hydrogels, the structural and biological roles of ECM can be restored for in vitro follicle development. The contribution of this work will be a single cell atlas of the reproductive-age ovary highlighting mechanisms driving follicle development and stromal cells’ supportive roles in folliculogenesis and a novel in vitro follicle culture system that supports human follicle development. The contribution of this work will be significant because it will guide the development of a standardized in vitro culture for maturation of human follicles and a safe fertility preservation option for patients unable to produce mature eggs as a result of gonadotoxic treatments. The proposed work is innovative in that it will be the first single cell dataset from healthy reproductive aged women and the first instance of human follicle culture in a synthetic ECM-sequestering matrix.
拟议研究的长期目标是为接受促性腺毒素抗癌治疗和面临不孕症的妇女建立一个广泛的生育保护选择。在实现上述目标和降低自体移植相关风险方面,本提案的总体目标是创造一个仿生环境,促进人类卵泡在体外从原始阶段开始发育。小卵泡培养的低成功率在很大程度上归因于卵泡细胞、邻近卵泡和基质细胞之间复杂且知之甚少的旁分泌、自分泌和内分泌信号。研究的核心假设是,人类卵泡的转录分析将揭示驱动发育的机制,并通过设计一种保留细胞分泌细胞外基质(ECM)的仿生水凝胶来重建卵巢微环境,从而支持人类卵泡的体外发育。这项工作的基本原理是,通过破译驱动卵泡激活和早期发育的机制,并在ecm隔离水凝胶中概括自然卵巢微环境,未来的培养系统可以转化为临床冷冻保存的卵巢卵泡成熟和随后的受精和怀孕。在第一个目标中,单细胞RNA测序将用于分析人类卵巢卵泡和支持性基质细胞。在第二个目标中,ECM隔离肽将加入到仿生聚乙二醇(PEG)水凝胶体系中,使用迈克尔型添加化学来促进ECM成分的沉积并模拟天然卵巢组织。卵泡的基底膜由ECM蛋白组成,它的功能是作为卵泡细胞的结构支持,分子进入卵泡的选择性屏障,以及保留可溶性生长因子和细胞因子的支架。它在卵泡发育过程中不断重塑,但细胞分泌的ECM分子不能粘附在未经修饰的PEG上进行自组装。通过将ECM隔离肽整合到PEG水凝胶中,可以恢复ECM在体外卵泡发育中的结构和生物学作用。这项工作的贡献将是一个生殖年龄卵巢的单细胞图谱,突出了驱动卵泡发育的机制和基质细胞在卵泡发生中的支持作用,以及一个支持人类卵泡发育的新型体外卵泡培养系统。这项工作的贡献将是重要的,因为它将指导人类卵泡成熟的标准化体外培养的发展,并为由于促性腺毒素治疗而无法产生成熟卵子的患者提供安全的生育保护选择。这项工作的创新之处在于,它将是第一个来自健康育龄妇女的单细胞数据集,也是第一个在合成ecm隔离基质中培养人类卵泡的实例。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrea Jones其他文献
Andrea Jones的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrea Jones', 18)}}的其他基金
Engineering a biomimetic matrix to promote development of human ovarian follicles in vitro
工程仿生基质促进人类卵泡体外发育
- 批准号:
10671614 - 财政年份:2021
- 资助金额:
$ 4.05万 - 项目类别:
相似国自然基金
益肺清化颗粒对血管生成因子及VEGF/KDR和Angiopoietins /Tie2信号传导通路的调控作用研究
- 批准号:30973841
- 批准年份:2009
- 资助金额:32.0 万元
- 项目类别:面上项目
相似海外基金
Evaluation of Angiopoietins as Prognostic Markers of Kidney Allograft Structure and Function
血管生成素作为肾同种异体移植结构和功能的预后标志物的评价
- 批准号:
10301502 - 财政年份:2021
- 资助金额:
$ 4.05万 - 项目类别:
Evaluation of Angiopoietins as Prognostic Markers of Kidney Allograft Structure and Function
血管生成素作为肾同种异体移植结构和功能的预后标志物的评价
- 批准号:
10487563 - 财政年份:2021
- 资助金额:
$ 4.05万 - 项目类别:
Evaluation of Angiopoietins as Prognostic Markers of Kidney Allograft Structure and Function
血管生成素作为肾同种异体移植结构和功能的预后标志物的评价
- 批准号:
10626144 - 财政年份:2021
- 资助金额:
$ 4.05万 - 项目类别:
Differential agonistic activities of angiopoietins on neutrophils
血管生成素对中性粒细胞的差异激动活性
- 批准号:
304873 - 财政年份:2014
- 资助金额:
$ 4.05万 - 项目类别:
Operating Grants
The Role of Angiopoietins 1 and 2 in ANCA Associated Vasculitis
血管生成素 1 和 2 在 ANCA 相关性血管炎中的作用
- 批准号:
MR/K000977/1 - 财政年份:2013
- 资助金额:
$ 4.05万 - 项目类别:
Fellowship
Expression and functional roles of angiopoietins in lymphangiogenesis and development of lymphatic induction system
血管生成素在淋巴管生成和淋巴诱导系统发育中的表达和功能作用
- 批准号:
21590217 - 财政年份:2009
- 资助金额:
$ 4.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Agonistic activities of angiopoietins on neutrophils
血管生成素对中性粒细胞的激动活性
- 批准号:
181135 - 财政年份:2009
- 资助金额:
$ 4.05万 - 项目类别:
Operating Grants
Elucidation of molecular mechanisms of angiogenesis mediated by angiopoietins and its application for asthma therapy
阐明血管生成素介导的血管生成的分子机制及其在哮喘治疗中的应用
- 批准号:
20590901 - 财政年份:2008
- 资助金额:
$ 4.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulation of skeletal muscle injury and regeneration by angiopoietins
血管生成素对骨骼肌损伤和再生的调节
- 批准号:
171081 - 财政年份:2008
- 资助金额:
$ 4.05万 - 项目类别:
Operating Grants
The Role of Tie2 and the Angiopoietins in EPC Biology
Tie2 和血管生成素在 EPC 生物学中的作用
- 批准号:
6999609 - 财政年份:2005
- 资助金额:
$ 4.05万 - 项目类别:














{{item.name}}会员




